- BioHarvest Sciences (BHSC) has received its Good Manufacturing Practices certification from the Israeli Ministry of Health
- The certification is for the company’s new manufacturing facility in Israel
- The facility will have the capacity to produce over 20 tonnes per year of BioHarvest’s products
- The company will provide its products to both direct-to-consumer and business-to-business customers
- BioHarvest Sciences is a biotechnology company that owns and develops proprietary bio-farming technology
- Shares in BioHarvest Sciences Inc. (BHSC) are down 2.56 per cent, trading at $0.38 per share
BioHarvest Sciences (BHSC) has received its Good Manufacturing Practices certification from the Israeli Ministry of Health.
The certification is for the company’s new manufacturing facility in Israel, which BioHarvest says will have the capacity to produce over 20 tonnes per year of VINIA and other products.
VINIA is BioHarvest’s flagship products contain all the benefits of red wine with the advantage of zero calories, zero sugar, and zero percent alcohol.
Pilot production of VINIA in the new facility has begun, and the capacity will be steadily increased each month to meet the growing demands of VINIA’s direct-to-consumer business in Israel, the United States, and future global markets.
Ilan Sobel, CEO of BioHarvest Sciences, commented on this important step forward for the company.
“From the first day I took the helm of the company,” he said, “I committed to operationalizing all of its arms.”
“Now that we have implemented the industrial manufacturing blueprint of our BioFarming technology in 12 months,” added Mr. Sobel, “we are confident in our ability to scale our technology and add on new verticals as in the case of cannabis.”
In addition to its direct-to-consumer business, BioHarvest will incorporate VINIA capacity for key business-to-business customers like Designs for Health Inc., which has already formulated VINIA into three new products.
“As a customer of BioHarvest, the GMP certification provides us with increased confidence in the company’s ability to increase the product delivery capacity while meeting our quality requirements,” said Chief Medical Officer of Designs for Health Dr. David Brady.
BioHarvest Sciences is a biotechnology company that owns and develops proprietary bio-farming technology.
Shares in BioHarvest Sciences Inc. (BHSC) are down 2.56 per cent, trading at $0.38 per share as of 11:02 am ET.
